1. Home
  2. Analysis
  3. Apixaban
  4. Jantoven

Apixaban and Jantoven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Apixaban and Jantoven together.

The phase IV clinical study analyzes what interactions people who take Apixaban and Jantoven have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

2 people who take Apixaban and Jantoven together, and have interactions are studied.

What is Apixaban?

Apixaban has active ingredients of apixaban. eHealthMe is studying from 49,427 Apixaban users for its effectiveness, alternative drugs and more.

What is Jantoven?

Jantoven has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 1,476 Jantoven users for its effectiveness, alternative drugs and more.

Number of Apixaban and Jantoven reports submitted per year:

Apixaban and Jantoven drug interactions.

Common Apixaban and Jantoven drug interactions by gender *:

female:

  1. Myocardial infarction
  2. Dyspepsia
  3. Hypoacusis

male:

  1. Anhedonia
  2. Anxiety
  3. Chronic kidney disease
  4. Death
  5. Emotional distress
  6. Nephrogenic anaemia
  7. Pain
  8. Renal failure

Common Apixaban and Jantoven drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Renal failure
  2. Anhedonia
  3. Anxiety
  4. Chronic kidney disease
  5. Death
  6. Emotional distress
  7. Nephrogenic anaemia
  8. Pain

40-49:

n/a

50-59:

n/a

60+:

  1. Dyspepsia
  2. Hypoacusis
  3. Myocardial infarction

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and Jantoven?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Apixaban and Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Apixaban side effects:

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Apixaban interactions:

Browse all interactions between Apixaban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Jantoven interactions:

Browse all interactions between Jantoven and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apixaban and warfarin sodium (the active ingredients of Apixaban and Jantoven, respectively), and Apixaban and Jantoven (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Apixaban and Jantoven.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.